(1 - 30 from 54
)
Rosenberg to J&J: Ditch Triple-A
online.barrons.com
[Barron's] - This alone should entitle him to offer some financial advice to Alex Gorsky, the new CEO of Johnson & Johnson (ticker: JNJ), who took over from William Weldon earlier this year. Don't worry about preserving your triple-A credit rating, says Rosenberg
Google News: Healthcare Business Recap: Johnson and Johnson Takeovers, St Jude Medical's ...
[Wall St. Cheat Sheet] - Johnson and Johnson's (NYSE:JNJ) new CEO Alex Gorsky wants to reinforce the firm's medical device division with takeovers, he said in an interview with Bloomberg, commenting that “We remain committed to cardiovascular, even though sales have fallen 44
Pharma rides a wave of targeted M&A deals
www.fiercepharma.com
[FiercePharma] - Incoming Johnson & Johnson ($JNJ) CEO Alex Gorsky says he's going to be looking around for buyouts. And so on. The reasons behind the dealmaking aren't new: Established markets are slowing down as emerging markets speed up, sending companies shopping
J&J CEO Gorsky Says Company Will Grow While Rivals Shrink
www.bloomberg.com
[Bloomberg] - When Alex Gorsky takes over as Johnson & Johnson (JNJ)'s chief executive officer today, he won't be shedding operations like his peers at Pfizer Inc. (PFE) and Abbott Laboratories. (ABT) He's looking to get bigger. Gorsky sees value in being a large
sorted by relevance / date